Deracoxib [169590-41-4]
D1869
Estimated Purity≥99%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameDeracoxib [169590-41-4]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥99%
- Format2mg/ml in DMSO
- Scientific DescriptionNSAID; COX-2 inhibitor.
- Storage InstructionAmbient
- UNSPSC12352200
References
- Ustün Alkan F, Ustüner O, et al. The effects of piroxicam and deracoxib on canine mammary tumour cell line. ScientificWorldJournal. 2012;2012:976740. PMID: 23251109. Bienhoff SE, Smith ES, Roycroft LM, et al. Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs. Vet Surg. 2012 Apr;41(3):336-44. PMID: 22225463. McMillan SK, Boria P, Moore GE, et al. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc. 2011 Oct 15;239(8):1084-9. PMID: 21985349. Blois SL, Allen DG, Wood RD, et al. Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs. Am J Vet Res. 2010 Mar;71(3):349-58. PMID: 20187838.